A strong association between the TGF-β signature and the exhausted immune signature in HCC was identified, suggesting that the TGF-β pathway is an important immune regulator and biomarker for HCC [32,74,75]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.